These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21536971)

  • 21. Histone deacetylase inhibitors exert time-dependent effects on nuclear factor-kappaB but consistently suppress the expression of proinflammatory genes in human myometrial cells.
    Lindström TM; Mohan AR; Johnson MR; Bennett PR
    Mol Pharmacol; 2008 Jul; 74(1):109-21. PubMed ID: 18375836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDAC inhibitors for the treatment of cancer.
    Secrist JP; Zhou X; Richon VM
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1422-7. PubMed ID: 14763127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species.
    Kang J; Chen J; Shi Y; Jia J; Zhang Y
    Biochem Pharmacol; 2005 Apr; 69(8):1205-13. PubMed ID: 15794941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein deacetylases: enzymes with functional diversity as novel therapeutic targets.
    Yoshida M; Shimazu T; Matsuyama A
    Prog Cell Cycle Res; 2003; 5():269-78. PubMed ID: 14593721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone deacetylase inhibitors: molecular mechanisms of action.
    Xu WS; Parmigiani RB; Marks PA
    Oncogene; 2007 Aug; 26(37):5541-52. PubMed ID: 17694093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential sensitivity of human leukemic cell lines to the histone deacetylase inhibitor, trichostatin A.
    Ninios YP; Sekeri-Pataryas KE; Sourlingas TG
    Leuk Res; 2010 Jun; 34(6):786-92. PubMed ID: 19782399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylation of non-histone proteins modulates cellular signalling at multiple levels.
    Spange S; Wagner T; Heinzel T; Krämer OH
    Int J Biochem Cell Biol; 2009 Jan; 41(1):185-98. PubMed ID: 18804549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo.
    Faraco G; Pittelli M; Cavone L; Fossati S; Porcu M; Mascagni P; Fossati G; Moroni F; Chiarugi A
    Neurobiol Dis; 2009 Nov; 36(2):269-79. PubMed ID: 19635561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting aberrant transcriptional repression in acute myeloid leukemia.
    Moe-Behrens GH; Pandolfi PP
    Rev Clin Exp Hematol; 2003 Jun; 7(2):139-59. PubMed ID: 14763160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
    Chen J; Du C; Kang J; Wang J
    Chem Biol Interact; 2008 Jan; 171(1):26-36. PubMed ID: 17961528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
    Rahim R; Strobl JS
    Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer.
    Johnstone RW
    Nat Rev Drug Discov; 2002 Apr; 1(4):287-99. PubMed ID: 12120280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simvastatin induces the odontogenic differentiation of human dental pulp stem cells in vitro and in vivo.
    Okamoto Y; Sonoyama W; Ono M; Akiyama K; Fujisawa T; Oshima M; Tsuchimoto Y; Matsuka Y; Yasuda T; Shi S; Kuboki T
    J Endod; 2009 Mar; 35(3):367-72. PubMed ID: 19249597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the Expression and Role of Histone Acetylation and Deacetylation in Dental Pulp Cells.
    Yamauchi Y; Duncan HF
    Methods Mol Biol; 2023; 2588():279-293. PubMed ID: 36418694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDAC inhibitors: roles of DNA damage and repair.
    Robert C; Rassool FV
    Adv Cancer Res; 2012; 116():87-129. PubMed ID: 23088869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibitors: a patent review (2009 - 2011).
    Carafa V; Miceli M; Altucci L; Nebbioso A
    Expert Opin Ther Pat; 2013 Jan; 23(1):1-17. PubMed ID: 23094822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer.
    Amnekar RV; Khan SA; Rashid M; Khade B; Thorat R; Gera P; Shrikhande SV; Smoot DT; Ashktorab H; Gupta S
    World J Gastroenterol; 2020 Feb; 26(6):598-613. PubMed ID: 32103870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDAC inhibitors as anti-inflammatory agents.
    Adcock IM
    Br J Pharmacol; 2007 Apr; 150(7):829-31. PubMed ID: 17325655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of HDACi-Induced Cytotoxicity.
    Marx-Blümel L; Marx C; Kühne M; Sonnemann J
    Methods Mol Biol; 2017; 1510():23-45. PubMed ID: 27761811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic modulation of dental pulp stem cells: implications for regenerative endodontics.
    Duncan HF; Smith AJ; Fleming GJ; Cooper PR
    Int Endod J; 2016 May; 49(5):431-46. PubMed ID: 26011759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.